Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Comparative effectiveness research could get economic stimulus

Executive Summary

House Democrats unveiled their $825 billion economic stimulus package, which will include $1.1 billion to be spent on comparative effectiveness research. The American Recovery and Reinvestment Bill of 2009, introduced Jan. 15 by the House Appropriations Committee, does not set up any separate comparative effectiveness research organization in connection with this financial outlay, but rather provides $700 million to the Agency for Healthcare Research and Quality and $400 million to the National Institutes of Health to carry out the research. The bill does, however, establish a Federal Coordinating Council for Comparative Effectiveness, with the purpose of working with federal agencies to coordinate or support research

House Democrats unveiled their $825 billion economic stimulus package, which will include $1.1 billion to be spent on comparative effectiveness research. The American Recovery and Reinvestment Bill of 2009, introduced Jan. 15 by the House Appropriations Committee, does not set up any separate comparative effectiveness research organization in connection with this financial outlay, but rather provides $700 million to the Agency for Healthcare Research and Quality and $400 million to the National Institutes of Health to carry out the research. The bill does, however, establish a Federal Coordinating Council for Comparative Effectiveness, with the purpose of working with federal agencies to coordinate or support research.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS050553

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel